THE DUBERSTEIN GROUP INC. for PFIZER INC.
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Corporate tax reform, including international taxes, tax extenders, deferral, excess returns/base erosion, territorial systems, patent/innovation box.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Trade (domestic/foreign) TRD
India treatment of intellecutal property - Executive Branch action re this issue. Trans Pacific Partnership negotiation - Executive Branch action re this issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Alcohol and Drug Abuse ALC
Opioid and prescription drug abuse - HR 672, Prescription Drug Abuse Prevention and Treatment Act of 2013; S 348, Prescription Drug Abuse Prevention and Treatment Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Budget/Appropriations BUD
Impact of fiscal deficit issues, debt ceiling, sequestration and health insurance taxes, on healthcare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Pharmacy PHA
Pharmaceutical issues, including track and trace legislation - HR 1919, Safeguarding America's Pharmaceuticals Act of 2013; S 957, Drug Supply Chain Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
Health Issues HCR
Healthcare provisions in the Administration's proposed budget; Federal Employee Health Benefits Plan. Modern Care Act. Dormant Therapies Act. Patients' Access to Treatments Act - HR 460, Patients' Access to Treatments Act of 2013.Implementation of the Patient Protection and Affordable Health Care Act. Drug shortages. Food and Drug Administration safety.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Medicare/Medicaid MMM
Medicare issues, including rebates, Medicare Advantage rate-setting, Part D and dual eligible rebates, non-interference, IPAB repeal. Non-interference.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.